MARKET INSIGHTS
Global (R)-N-BOC-2-Bromophenylalanine (CAS 261360-76-3) market size was valued at USD 48.6 million in 2025. The market is projected to grow from USD 52.1 million in 2026 to USD 89.4 million by 2034, exhibiting a CAGR of 6.2% during the forecast period.
(R)-N-BOC-2-Bromophenylalanine (CAS 261360-76-3) is a protected, enantiomerically pure unnatural amino acid derivative featuring a tert-butoxycarbonyl (BOC) protecting group on the amine functionality and a bromine substituent at the ortho position of the phenylalanine aromatic ring. This chiral building block is widely utilized in pharmaceutical synthesis, peptide chemistry, and the development of complex organic molecules, offering high stereochemical fidelity essential for drug discovery and medicinal chemistry applications.
The market is steadily expanding, driven by growing demand for chiral intermediates in the pharmaceutical sector and the increasing complexity of peptide-based therapeutics under development. Furthermore, the compound’s versatility in cross-coupling reactions – particularly Suzuki and Buchwald-Hartwig reactions – makes it a valued synthetic tool in medicinal chemistry workflows. Key suppliers operating in this space include Sigma‑Aldrich (Merck KGaA), TCI Chemicals, and Bachem AG, among other specialty fine chemical manufacturers.
(R)-N-BOC-2-Bromophenylalanine (CAS 261360-76-3) Market – View in Detailed Research Report
10. 1. Biosynth AG
Headquarters: Switzerland
Key Offering: High‑purity (R)-N-BOC-2‑Bromophenylalanine, custom synthesis, and cGMP‑compliant production
Biosynth AG is a leading manufacturer of chiral amino acid derivatives, providing scalable production of (R)-N-BOC-2‑Bromophenylalanine for pharmaceutical and research applications. Their state‑of‑the‑art facilities enable rapid turnaround for both standard and ultra‑high purity grades, supporting advanced peptide therapeutics and medicinal chemistry projects.
Sustainability & Growth Initiatives: Investment in green chemistry processes, including solvent‑reduction and waste‑minimization strategies, to lower environmental impact and improve cost efficiency.
- Adoption of renewable energy sources for manufacturing operations
- Development of continuous flow synthesis to reduce batch waste
- Partnerships with biotech firms for custom scale‑up projects
10. 2. Iris Biotech GmbH
Headquarters: Germany
Key Offering: Catalog and custom protected amino acids, including (R)-N-BOC-2‑Bromophenylalanine
Iris Biotech GmbH specializes in high‑quality protected amino acids for research and industrial use. Their extensive library and rapid custom synthesis services make them a preferred supplier for peptide chemists and pharmaceutical developers worldwide.
Sustainability & Growth Initiatives: Focus on sustainable sourcing of raw materials and implementation of closed‑loop recycling in production.
- Eco‑friendly sourcing of Boc anhydride and brominated precursors
- Implementation of waste‑water treatment protocols
- Collaborations with academic institutions for green chemistry research
10. 3. Bachem AG
Headquarters: Switzerland
Key Offering: High‑purity (R)-N-BOC-2‑Bromophenylalanine, custom synthesis, and cGMP‑compliant production
Bachem AG is renowned for its high‑quality chiral building blocks, offering extensive support for peptide synthesis and drug development. Their robust quality control and global distribution network ensure consistent supply for research and pharmaceutical clients.
Sustainability & Growth Initiatives: Commitment to reducing carbon footprint and enhancing energy efficiency across manufacturing sites.
- Deployment of energy‑efficient HVAC systems
- Investment in renewable electricity for production facilities
- Continuous improvement of process yields to reduce material consumption
10. 4. Pharmablock Sciences
Headquarters: China
Key Offering: Large‑scale production of (R)-N-BOC-2‑Bromophenylalanine and custom synthesis services
Pharmablock Sciences has rapidly expanded its manufacturing capabilities, providing cost‑effective production of chiral amino acids for the growing Asian biopharma market. Their advanced facilities support high‑volume demand while maintaining stringent quality standards.
Sustainability & Growth Initiatives: Integration of green chemistry principles and process optimization to reduce waste.
- Implementation of solvent‑recycling systems
- Optimization of reaction conditions for higher yields
- Collaboration with regional CROs to support custom projects
10. 5. GL Biochem Ltd.
Headquarters: China
Key Offering: Bulk production and custom synthesis of (R)-N-BOC-2‑Bromophenylalanine
GL Biochem Ltd. serves the pharmaceutical and fine chemical markets with reliable supply of chiral intermediates. Their focus on scalable processes and regulatory compliance positions them as a trusted partner for global clients.
Sustainability & Growth Initiatives: Emphasis on energy efficiency and waste minimization.
- Adoption of energy‑saving manufacturing technologies
- Implementation of zero‑liquid‑discharge protocols
- Partnerships with environmental agencies for compliance
10. 6. Enamine Ltd.
Headquarters: Ukraine
Key Offering: Extensive building block library and custom synthesis of (R)-N-BOC-2‑Bromophenylalanine
Enamine Ltd. offers a wide range of chiral building blocks, including (R)-N-BOC-2‑Bromophenylalanine, supporting medicinal chemistry and peptide research worldwide. Their flexible synthesis platform enables rapid delivery of custom orders.
Sustainability & Growth Initiatives: Focus on green synthesis and process scalability.
- Development of catalytic, low‑energy processes
- Use of renewable solvents where possible
- Continuous improvement of process safety and waste reduction
10. 7. TCI Chemicals
Headquarters: Japan
Key Offering: High‑purity (R)-N-BOC-2‑Bromophenylalanine and advanced specialty chemicals
TCI Chemicals supplies a broad portfolio of specialty chemicals, with a strong focus on chiral amino acid derivatives. Their R&D investments drive innovation in synthesis methods and support diverse applications in pharma and research.
Sustainability & Growth Initiatives: Commitment to green chemistry and regulatory compliance.
- Implementation of eco‑friendly production protocols
- Adherence to REACH and other regulatory frameworks
- Collaboration with academic partners for sustainable development
10. 8. AnaSpec
Headquarters: USA
Key Offering: Specialty fine chemicals and custom synthesis of (R)-N-BOC-2‑Bromophenylalanine
AnaSpec provides high‑quality reagents for research and industrial use, emphasizing purity and consistency. Their custom synthesis capabilities cater to niche applications in peptide chemistry and drug discovery.
Sustainability & Growth Initiatives: Focus on efficient resource use and waste reduction.
- Optimization of reaction conditions for higher atom economy
- Use of recyclable catalysts and solvents
- Implementation of waste‑minimization protocols
10. 9. Bachem Americas Inc.
Headquarters: USA
Key Offering: High‑purity (R)-N-BOC-2‑Bromophenylalanine, custom synthesis, and cGMP‑compliant production
Bachem Americas Inc. extends the global reach of Bachem AG’s high‑quality chiral building blocks to North American markets, ensuring reliable supply for pharmaceutical development and research.
Sustainability & Growth Initiatives: Integration of sustainable manufacturing practices.
- Adoption of renewable energy sources for production sites
- Implementation of closed‑loop water systems
- Partnerships with local biotech firms for custom scale‑up
10. 10. Oakwood Chemical
Headquarters: USA
Key Offering: Specialty chemicals and custom synthesis of (R)-N-BOC-2‑Bromophenylalanine
Oakwood Chemical focuses on delivering high‑purity reagents for research and industrial applications, with an emphasis on rapid turnaround and customer‑centric service.
Sustainability & Growth Initiatives: Commitment to eco‑friendly processes and efficient resource utilization.
- Implementation of green solvent systems
- Energy‑efficient manufacturing equipment
- Continuous improvement of process safety and waste reduction
Outlook: The Future of (R)-N-BOC-2-Bromophenylalanine Market
The (R)-N-BOC-2‑Bromophenylalanine market is poised for sustained growth, driven by the expanding peptide therapeutics sector, increasing demand for chiral intermediates, and the compound’s versatile role in advanced cross‑coupling chemistry. Market analysts forecast a CAGR of 6.2% from 2025 to 2034, reflecting continued investment in biopharma R&D and the adoption of novel peptide‑based modalities.
Key Trends Shaping the Market
- Rapid expansion of peptide‑based drug pipelines, especially in oncology and neurology
- Growing adoption of automated solid‑phase peptide synthesis (SPPS) and flow chemistry for high‑throughput production
- Increased focus on sustainable synthesis, including green Boc‑protection strategies and solvent recycling
- Emergence of PROTACs and ADCs leveraging the bromine handle for click chemistry and bioconjugation
- Strategic partnerships between fine‑chemical manufacturers and biotech firms to accelerate custom scale‑up and supply chain resilience
- Top 10 Companies in the Russia Iron Oxide Red Market (2026): Market Leaders Shaping Russia’s Pigment Landscape - May 21, 2026
- Top 10 Companies in the (R)-N-BOC-2-Bromophenylalanine (CAS 261360-76-3) Market (2026): Market Leaders Driving Global Biopharma Innovation - May 21, 2026
- Top 10 Companies in the Medium Temperature Tar Pitch Market (2026): Market Leaders Powering Global Industry - May 21, 2026